ShaadEssaAbedinMDFACP(He/Him)
Oncology • Chevy Chase, MDBreast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Physician
Dr. Abedin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6800 Wisconsin Ave
#1125
Chevy Chase, MD 20815Phone+1 240-200-4115Fax+1 646-349-7620
Summary
- Physician scientist and healthcare consultant with 10+ year experience in exploratory research and clinical drug development. Shaad is a practicing physician who is board certified in internal medicine, hematology & medical oncology, with a diverse skill set of preclinical lab based experience, Phase 1 to 3 Trial design & strategy, global execution and approvals.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2009 - 2012
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2006 - 2009
Dow University of Health SciencesClass of 2004
Certifications & Licensure
MD State Medical License 2012 - 2026
VA State Medical License 2012 - 2026
DC State Medical License 2013 - 2024
FL State Medical License 2020 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians, 2015
- Young Investigator Award American Society of Clinical Oncology, 2012
- CMS Meaningful Use Stage 1 Certification SuiteMed EMR, Fox Meadows Software, 2013
Publications & Presentations
PubMed
- 1 citationsTebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action.Jessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, Devayani Machiraju, Alexander Enk
The Journal of Investigative Dermatology. 2024-07-15 - 10 citationsTebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study.Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer
Journal for Immunotherapy of Cancer. 2023-06-01 - 64 citationsClinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi
Nature Medicine. 2022-11-01
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
External Links
- Websitehttp://www.fda.gov/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
